Impact of myocardial perfusion abnormality on prognosis in patients with non-ischemic dilated cardiomyopathy

被引:10
|
作者
Sobajima, Mitsuo [1 ]
Nozawa, Takashi [1 ]
Suzuki, Takayuki [1 ]
Ohori, Takashi [1 ]
Shida, Takuya [1 ]
Matsuki, Akira [1 ]
Inoue, Hiroshi [1 ]
机构
[1] Toyama Univ, Grad Sch Med, Dept Internal Med 2, Toyama 9300194, Japan
关键词
Radionuclide; Myocardial perfusion; Non-ischemic dilated cardiomyopathy; Ventricular arrhythmias; WALL-MOTION ABNORMALITIES; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MAGNETIC-RESONANCE; CORONARY-ARTERY-DISEASE; BUNDLE-BRANCH BLOCK; HYPERTROPHIC CARDIOMYOPATHY; VENTRICULAR-FUNCTION; BLOOD-FLOW; RESERVE; STRESS;
D O I
10.1016/j.jjcc.2010.06.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Myocardial perfusion imaging shows various patterns in patients with non-ischemic dilated cardiomyopathy (DCM). However, influences of regional abnormalities of myocardial perfusion or ventricular wall motion on prognosis in DCM patients remains to be clarified. Accordingly, we investigated a relation between myocardial perfusion patterns and long-term prognosis in DCM patients. Methods and results: Sixty-two patients were divided into 2 groups according to patterns of Tc-99m-Tetrofosmin scintigraphy, i.e. large focal defects (focal) and minimally impaired perfusion or multiple small defects (non-focal). There were no differences between the 2 groups in left ventricular (LV) end-diastolic dimensions (63.4 +/- 9.1 and 63.8.4 +/- 7.5 mm, respectively) and LV ejection fraction (30.3 +/- 9.2 and 27.9 +/- 7.8%, respectively), indicating LV systolic dysfunction was comparable between the groups. The focal group had a higher prevalence of brain natriuretic peptide >= 200 ng/dl and plasma norepinephrine >= 500 pg/ml than the non-focal group (p < 0.05), and had longer QRS durations (p < 0.05). The focal group had non-sustained ventricular tachycardia (VT) (p < 0.05) on 24-h electrocardiogram recording and a history of VT/ventricular fibrillation more frequently (p < 0.05), and had higher New York Heart Association functional class than the non-focal group (p < 0.05). The mortality was significantly higher in the focal group (56.0%) than in the non-focal group (28.6%) and the survival curves revealed worse prognosis in the focal group during a follow-up period of 5.3 +/- 2.8 years. Conclusions: Non-ischemic DCM patients with focal defects are accompanied by more advanced heart failure and poor prognosis compared to those with minimally impaired perfusion or multiple small defects, despite comparable LV systolic dysfunction. (C) 2010 Japanese College of Cardiology. Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:280 / 286
页数:7
相关论文
共 50 条
  • [21] Non-ischemic dilated cardiomyopathy and cardiac fibrosis
    Cojan-Minzat, Bianca Olivia
    Zlibut, Alexandru
    Agoston-Coldea, Lucia
    HEART FAILURE REVIEWS, 2021, 26 (05) : 1081 - 1101
  • [22] The impact of type 2 diabetes mellitus on the clinical profile, myocardial fibrosis, and prognosis in non-ischemic dilated cardiomyopathy: a prospective cohort study
    Li, Yangjie
    Xian, Hong
    Xu, Yuanwei
    Li, Weihao
    Guo, Jiajun
    Wan, Ke
    Wang, Jie
    Xu, Ziqian
    Zhang, Qing
    Han, Yuchi
    Sun, Jiayu
    Chen, Yucheng
    CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)
  • [23] The impact of type 2 diabetes mellitus on the clinical profile, myocardial fibrosis, and prognosis in non-ischemic dilated cardiomyopathy: a prospective cohort study
    Yangjie Li
    Hong Xian
    Yuanwei Xu
    Weihao Li
    Jiajun Guo
    Ke Wan
    Jie Wang
    Ziqian Xu
    Qing Zhang
    Yuchi Han
    Jiayu Sun
    Yucheng Chen
    Cardiovascular Diabetology, 23
  • [24] SPIRONOLACTONE IMPROVES SUBENDOCARDIAL MYOCARDIAL PERFUSION, INCREASES MYOCARDIAL ENERGY SUPPLY, AND REVERSES LV REMODELING IN NON-ISCHEMIC DILATED CARDIOMYOPATHY
    Bell, Susan P.
    Adkisson, Douglas
    Lawson, Mark
    Wang, Li
    Ooi, Henry
    Sawyer, Douglas
    Kronenberg, Marvin
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E579 - E579
  • [25] Evaluation of Myocardial Fibrosis in Non-ischemic Dilated Cardiomyopathy and its Prognostic Value
    Kayvanpour, Elham
    Sedaghat-Hamedani, Farbod
    Li, Daniel
    Tugrul, Firat
    Grabe, Niels
    Lahrmann, Bernd
    Frankenstein, Lutz
    Stock, Christian
    Herpel, Esther
    Buss, Sebastian
    Katus, Hugo A.
    Meder, Benjamin
    INTERNIST, 2017, 58 : S32 - S32
  • [26] Shared Genetic Burden of Ischemic and Non-Ischemic Dilated Cardiomyopathy
    Cao, Louie
    Rushakoff, Joshua
    Zhang, Zijun
    Williamson, Ian
    Karlstaedt, Anja
    Kittleson, Michelle
    Czer, Lawrence
    Kransdorf, Evan
    CIRCULATION, 2024, 150
  • [27] Impaired Subendocardial Perfusion in Human Non-Ischemic Dilated Cardiomyopathy: A mechanism for Energy Starvation
    Adkisson, Douglas W.
    Kronenberg, Marvin W.
    Dendy, Jeffrey M.
    Ooi, Henry
    Sawyer, Douglas B.
    Lawson, Mark
    CIRCULATION, 2009, 120 (18) : S907 - S908
  • [28] Coronary microcirculation changes in non-ischemic dilated cardiomyopathy identified by novel perfusion CT
    Wayne L. Miller
    Thomas R. Behrenbeck
    Cynthia H. McCollough
    Eric E. Williamson
    Shuai Leng
    Timothy L. Kline
    Erik L. Ritman
    The International Journal of Cardiovascular Imaging, 2015, 31 : 881 - 888
  • [29] Coronary microcirculation changes in non-ischemic dilated cardiomyopathy identified by novel perfusion CT
    Miller, Wayne L.
    Behrenbeck, Thomas R.
    McCollough, Cynthia H.
    Williamson, Eric E.
    Leng, Shuai
    Kline, Timothy L.
    Ritman, Erik L.
    INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2015, 31 (04): : 881 - 888
  • [30] Whole exome sequence analysis in patients with non-ischemic dilated cardiomyopathy
    Sezenoz, Burak
    Nurdan, Fevzi
    Ergun, Mehmet Ali
    Tastan, Hakki
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2022, 26 : S139 - S141